ELMSFORD, N.Y., Sept. 3, 2019 /PRNewswire/ -- NanoVibronix,
Inc., (NASDAQ: NAOV), a medical device company that
produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra
Sonic therapeutic device, announces on August 18th, 2019, PainShield, and PainShield
Supplies were added to the Federal Supply Schedule through
NanoVibronix' relationship with Marathon Medical, a Service
Disabled Veteran Owned Small Business (SDVOSB) headquartered in
Aurora, Colorado. Accordingly,
Marathon Medical can now sell PainShield and related supplies to
the Veterans Health Administration, the largest integrated health
care system in the United States,
providing care at 1,255 health care facilities, including 170 VA
Medical Centers and 1,074 outpatient sites of care of varying
complexity, and the U.S. Department of Justice to combat pain
and provide an opioid alternative pain management system.
The Veterans Health Administration (VA) has launched an Opioid
Safety Initiative (OSI), designed to address the growing epidemic
of opioid misuse and opioid use disorder in America. It is
estimated that chronic pain is a common condition for nearly 20
million Veterans, and more than 50% of the nearly nine million
Veterans enrolled in the VA health care system are receiving
treatment each year for chronic pain. PainShield provides a proven,
opioid-free alternative to relieve pain for Veterans and others,
in-line with the goals of this initiative.
Brian Murphy, CEO of NanoVibronix
Inc. said, "Our collaboration with Marathon Medical, a leading
veteran-owned business, will help put proven solutions in the hands
of our Veterans to help address chronic pain while avoiding the
dangers of opioids. Securing a Federal Supply Schedule number was a
key step in this effort, creating a new and exciting market for our
technology."
About Marathon Medical
Marathon Medical is a medical supply distribution company
founded in 2002. Its mission is to provide excellence to the health
care supply chain with professional personal service. Marathon
Medical's corporate offices and warehouse facility is conveniently
located just outside of Denver, CO
with an additional location in Tampa,
FL. Marathon Medical works with a variety of manufacturers
including its own private label products to provide solutions for
every department within the hospital. Marathon Medical remembers
those in service by donating to the Wheel-Chair Games, Danny Dietz Memorial, and the Navy Seal Fund.
More information on Marathon Medical can be found at:
https://www.marathonmed.com/topic/about
About NanoVibronix
NanoVibronix Inc. (NASDAQ: NAOV) is a medical device company
headquartered in Elmsford, New
York, with research and development in Nesher, Israel, which is focused on developing medical
devices utilizing its proprietary and patented low intensity
surface acoustic wave (SAW) technology. This technology allows for
the creation of low-frequency ultrasound waves that can be utilized
for a variety of medical applications, including the disruption of
biofilms and bacteria colonization, as well as providing pain
relief. The devices can be administered at home without the
assistance of medical professionals. The Company's primary products
include PainShield®, UroShield™ and WoundShield™. Additional
information about the Company is available at:
www.nanovibronix.com.
Forward-looking Statements
This press release contains "forward-looking statements."
Such statements may be preceded by the words "intends," "may,"
"will," "plans," "expects," "anticipates," "projects," "predicts,"
"estimates," "aims," "believes," "hopes," "potential" or similar
words. Forward-looking statements are not guarantees of future
performance, are based on certain assumptions and are subject to
various known and unknown risks and uncertainties, many of which
are beyond the Company's control, and cannot be predicted or
quantified and consequently, actual results may differ materially
from those expressed or implied by such forward-looking statements.
Such risks and uncertainties include, without limitation, risks and
uncertainties associated with (i) market acceptance of our existing
and new products or lengthy product delays in key markets; (ii)
negative or unreliable clinical trial results (iii) an inability to
secure regulatory approvals for the sale of our products, (iv)
intense competition in the medical device industry from much
larger, multinational companies, (v) product liability claims, (vi)
product malfunctions, (vii) our limited manufacturing capabilities
and reliance on subcontractors for assistance, (viii) insufficient
or inadequate reimbursement by governmental and other third party
payers for our products, (ix) our efforts to successfully obtain
and maintain intellectual property protection covering our
products, which may not be successful, (x) legislative or
regulatory reform of the healthcare system in both the U.S. and
foreign jurisdictions, (xi) our reliance on single suppliers for
certain product components, (xii) the fact that we will need to
raise additional capital to meet our business requirements in the
future and that such capital may not be available, or may be
costly, dilutive or difficult to obtain and (xiii) the fact that we
conduct business in multiple foreign jurisdictions, exposing us to
foreign currency exchange rate fluctuations, logistical and
communications challenges, burdens and costs of compliance with
foreign laws and political and economic instability in each
jurisdiction. More detailed information about the Company and the
risk factors that may affect the realization of forward looking
statements is set forth in the Company's filings with the
Securities and Exchange Commission (SEC), including the Company's
Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.
Investors and security holders are urged to read these documents
free of charge on the SEC's web site at http://www.sec.gov. The
Company assumes no obligation to publicly update or revise its
forward-looking statements as a result of new information, future
events or otherwise.
View original
content:http://www.prnewswire.com/news-releases/nanovibronix-and-marathon-medical-to-provide-painshield-to-va-hospitals-and-the-department-of-justice-300909593.html
SOURCE NanoVibronix, Inc